KPTSF (KP Tissue) EV-to-EBIT: (As of Jul. 27, 2026)

KP Tissue  (OTCPK:KPTSF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

KP Tissue's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

KP Tissue's Enterprise Value for the quarter that ended in Mar. 2026 was $78.67 Mil.
KP Tissue's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

KP Tissue EV-to-EBIT Related Terms

The historical data trend for KP Tissue's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

KP Tissue EV-to-EBIT Chart

KP Tissue Annual Data
	Trend	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24	Dec25
EV-to-EBIT		Get a 7-Day Free Trial					0.00	0.00	0.00	0.00	0.00

KP Tissue Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
EV-to-EBIT	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

KPTSF vs PG, CL, KVUE: EV-to-EBIT Comparison

For the Household & Personal Products subindustry, KP Tissue's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

KP Tissue EV-to-EBIT vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, KP Tissue's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where KP Tissue's EV-to-EBIT falls into.

KP Tissue EV-to-EBIT Calculation

KP Tissue's EV-to-EBIT for today is calculated as:

KP Tissue's current Enterprise Value is $90.84 Mil.
KP Tissue's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

KP Tissue Business Description